HRCM
Hood River Capital Management Portfolio holdings
AUM
$7.16B
1-Year Return
73.55%
This Quarter Return
+18.13%
1 Year Return
+73.55%
3 Year Return
+445.89%
5 Year Return
+1,002.72%
10 Year Return
+7,216.95%
AUM
$6.19B
AUM Growth
+$1.37B
(+28%)
Cap. Flow
+$794M
Cap. Flow
% of AUM
12.82%
Top 10 Holdings %
Top 10 Hldgs %
24.49%
Holding
177
New
33
Increased
95
Reduced
14
Closed
35
Top Buys
| 1 |
Semtech
SMTC
|
$155M |
| 2 |
QXO
QXO Inc
QXO
|
$61.5M |
| 3 |
SiTime
SITM
|
$57M |
| 4 |
Western Alliance Bancorporation
WAL
|
$56.2M |
| 5 |
EXL Service
EXLS
|
$51M |
Top Sells
| 1 |
FTAI Aviation
FTAI
|
$152M |
| 2 |
Rambus
RMBS
|
$127M |
| 3 |
Onto Innovation
ONTO
|
$84M |
| 4 |
Camtek
CAMT
|
$73.3M |
| 5 |
Vertiv
VRT
|
$65.6M |
Sector Composition
| 1 | Industrials | 26.95% |
| 2 | Technology | 26.04% |
| 3 | Healthcare | 24.26% |
| 4 | Consumer Discretionary | 7.87% |
| 5 | Financials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Viking Therapeutics
VKTX
$2.87B
| $51.6M | 0.83% |
815,678
+101,100
| +14% | +$6.4M |
|
|
52
EXL Service
EXLS
$7.14B
| $51M | 0.82% |
+1,337,786
| New | +$51M |
|
53
Ciena
CIEN
$16.8B
| $49.6M | 0.8% |
+805,981
| New | +$49.6M |
|
54
Customers Bancorp
CUBI
$2.15B
| $48.8M | 0.79% |
1,049,616
+500,553
| +91% | +$23.3M |
|
55
Biohaven
BHVN
$1.53B
| $45.1M | 0.73% |
902,888
+533,986
| +145% | +$26.7M |
|
56
Victoria's Secret
VSCO
$2.05B
| $44.6M | 0.72% |
+1,735,948
| New | +$44.6M |
|
|
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $43.9M | 0.71% |
599,991
+112,473
| +23% | +$8.23M |
|
58
Crinetics Pharmaceuticals
CRNX
$3.31B
| $42.7M | 0.69% |
834,912
+424,570
| +103% | +$21.7M |
|
59
Alignment Healthcare
ALHC
$3.21B
| $41.9M | 0.68% |
3,547,783
+441,093
| +14% | +$5.21M |
|
60
FTAI Infrastructure
FIP
$465M
| $41.6M | 0.67% |
4,439,273
+1,482,110
| +50% | +$13.9M |
|
|
VRNA
61
Verona Pharma
VRNA
$9.19B
| $41.3M | 0.67% |
1,433,934
+371,478
| +35% | +$10.7M |
|
62
DigitalOcean
DOCN
$3.03B
| $41.1M | 0.66% |
1,018,042
+194,386
| +24% | +$7.85M |
|
63
TG Therapeutics
TGTX
$5.14B
| $38.1M | 0.62% |
1,630,349
+57,420
| +4% | +$1.34M |
|
64
Genius Sports
GENI
$3.04B
| $37.1M | 0.6% |
4,730,748
+2,703,875
| +133% | +$21.2M |
|
65
Evolent Health
EVH
$1.12B
| $36.5M | 0.59% |
1,292,379
-325,073
| -20% | -$9.19M |
|
66
Fabrinet
FN
$13.2B
| $35.8M | 0.58% |
+151,504
| New | +$35.8M |
|
67
SPX Corp
SPXC
$9.34B
| $34.4M | 0.56% |
215,802
+28,265
| +15% | +$4.51M |
|
68
Smith Douglas Homes
SDHC
$1.07B
| $34.2M | 0.55% |
+903,951
| New | +$34.2M |
|
69
American Superconductor
AMSC
$2.26B
| $33.8M | 0.55% |
1,431,940
-303,074
| -17% | -$7.15M |
|
70
TFI International
TFII
$7.9B
| $33.5M | 0.54% |
244,864
+29,848
| +14% | +$4.09M |
|
71
MoonLake Immunotherapeutics
MLTX
$3.88B
| $32.6M | 0.53% |
+646,662
| New | +$32.6M |
|
72
Immunovant
IMVT
$2.85B
| $32.6M | 0.53% |
+1,143,567
| New | +$32.6M |
|
73
Rhythm Pharmaceuticals
RYTM
$6.63B
| $32.2M | 0.52% |
+614,598
| New | +$32.2M |
|
74
Couchbase
BASE
$1.35B
| $32M | 0.52% |
1,982,074
+352,181
| +22% | +$5.68M |
|
75
Parsons
PSN
$8.01B
| $31.9M | 0.52% |
+307,889
| New | +$31.9M |
|